PHM7 COST SIMULATION OF NOVOSEVEN VERSUS FEIBAAND ITT-F8 FOR PRIMARY PROPHYLAXIS TREATMENT OF HAEMOPHILIA A/B PATIENTS WITH INHIBITORS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65034-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65034-6/fulltext
Title :
PHM7 COST SIMULATION OF NOVOSEVEN VERSUS FEIBAAND ITT-F8 FOR PRIMARY PROPHYLAXIS TREATMENT OF HAEMOPHILIA A/B PATIENTS WITH INHIBITORS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65034-6&doi=10.1016/S1098-3015(10)65034-6
First page :
Section Title :
Open access? :
No
Section Order :
193